XML 18 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities    
Net income $ (4,874) $ (6,112)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 27,721 29,925
Deferred income tax 0 1
Non-cash interest expense 276 203
Non-cash stock compensation 10,427 11,515
Impairment of long-lived assets and related purchase commitments (122) 646
Loss on disposal of property and equipment 0 154
Impairment of long-lived assets and related purchase commitments 2,213 2,736
Changes in operating assets and liabilities:    
Accounts receivable (22,032) 13,916
Inventories 106 2,269
Prepaid expenses and other current assets (818) 117
Deferred costs - eyewear (236) (42)
Other assets (97) (3,286)
Accounts payable 4,065 (7,137)
Accrued expenses and other liabilities 2,540 2,347
Other long-term liabilities (654) (783)
Income taxes receivable/payable 594 (1,152)
Deferred revenue 8,747 (5,224)
Net cash provided by operating activities 27,856 40,093
Cash flows from investing activities    
Purchases of property and equipment (871) (4,032)
Purchases of cinema systems and related components (10,102) (12,626)
Proceeds from sale of property and equipment 0 79
Net cash used in investing activities (10,973) (16,579)
Cash flows from financing activities    
Proceeds from Credit Agreement 12,700 37,300
Repayments on Credit Agreement (7,182) (41,845)
Payments of debt issuance costs 0 (895)
Proceeds from exercise of stock options 1,245 2,782
Proceeds from employee stock purchase plan 562 291
Repurchase of statutory withholdings of stock issued for restricted stock units (1,773) (990)
Net cash provided by (used in) financing activities 5,552 (3,357)
Effect of currency exchange rate changes on cash and cash equivalents (1,297) 2,793
Net increase in cash and cash equivalents 21,138 22,950
Cash and cash equivalents, beginning of period 60,333 28,800
Cash and cash equivalents, end of period $ 81,471 $ 51,750